New York Psilocybin Update

In January 2021, New York State Senator Jabari Brisport introduced a bill that would decriminalize the possession, sale, and use of psilocybin and other psychedelic substances. The bill would also establish a regulatory framework for the use of these substances in medical and therapeutic settings.


The bill has received support from advocates who believe that psilocybin and other psychedelics could have significant medical benefits, including treating depression, anxiety, and post-traumatic stress disorder (PTSD). Studies have shown that psilocybin can lead to long-lasting positive effects on mental health and well-being.


While the bill did not pass, the state has already taken steps to support research into psilocybin’s potential benefits. In March 2021, the New York State Health Department announced that it was launching a study on the potential benefits of psilocybin in treating mental health conditions.


Recently A group of New York state lawmakers introduced a bill to legalize natural psychedelics including psilocybin, the primary psychoactive compound in “magic mushrooms. “This would amend New York state law to legalize the “possession, use, cultivation, production, creation, analysis, gifting, exchange, or sharing by or between natural persons of twenty-one years of age or older of a natural plant or fungus-based hallucinogen.” The bill would apply to natural psychedelics including DMT, ibogaine, mescaline, psilocybin and psilocin.


The legislation also legalizes the use of natural psychedelics for religious purposes and allows people to provide psychedelic services “with or without remuneration.” “The bill also gives legal protections to individuals who lawfully use natural psychedelics. Under the measure, it is not legal to deny professional licenses, public benefits, or mental or behavioral health services based on the lawful use of natural psychedelics, and such use could not be the only basis for a child welfare investigation.” According to Forbes.